FASTING MIMICKING TECHNOLOGY Trademark

Trademark Overview


On Thursday, April 14, 2022, a trademark application was filed for FASTING MIMICKING TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the FASTING MIMICKING TECHNOLOGY trademark a serial number of 97364195. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, June 11, 2024. This trademark is owned by L-Nutra Inc.. The FASTING MIMICKING TECHNOLOGY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations, namely, epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; Pharmaceutical preparations, namely, epigenetic drugs targeting arginine methylation in cancer; pharmaceutical preparations in the nature of inhibitors of arginine methylation for the treatment of cancer; pharmaceutical preparations in the nature of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; pharmaceutical compounds for the treatment, diagnosis, detection and prevention of cancer; pharmaceutical preparations for the treatment, diagnosis, detection and prevention of cancer; Pharmaceutical preparations, namely, biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer

Research and development services in the pharmaceutical and biotechnology fields; medical research and development services in the pharmaceutical and biotechnology fields; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and prevention of cancer; research a...
fasting mimicking technology

General Information


Serial Number97364195
Word MarkFASTING MIMICKING TECHNOLOGY
Filing DateThursday, April 14, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, June 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; Pharmaceutical preparations, namely, epigenetic drugs targeting arginine methylation in cancer; pharmaceutical preparations in the nature of inhibitors of arginine methylation for the treatment of cancer; pharmaceutical preparations in the nature of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; pharmaceutical compounds for the treatment, diagnosis, detection and prevention of cancer; pharmaceutical preparations for the treatment, diagnosis, detection and prevention of cancer; Pharmaceutical preparations, namely, biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer
Section 2(f) Limitation Statementas to "FASTING MIMICKING"
NOT AVAILABLE"TECHNOLOGY"
Goods and ServicesResearch and development services in the pharmaceutical and biotechnology fields; medical research and development services in the pharmaceutical and biotechnology fields; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer; consultancy, advisory and information services relating to and connected with the aforementioned services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 20, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameL-Nutra Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPLANO, TX 75024

Party NameL-Nutra Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPlano, TX 75024

Trademark Events


Event DateEvent Description
Monday, April 18, 2022NEW APPLICATION ENTERED
Wednesday, April 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 21, 2022ASSIGNED TO EXAMINER
Monday, September 26, 2022ASSIGNED TO EXAMINER
Friday, October 7, 2022NON-FINAL ACTION WRITTEN
Friday, October 7, 2022NON-FINAL ACTION E-MAILED
Friday, October 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 1, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, May 1, 2023EXAMINERS AMENDMENT E-MAILED
Monday, May 1, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 1, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, May 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 17, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 6, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 1, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 24, 2024SOU EXTENSION 1 FILED
Wednesday, January 24, 2024SOU EXTENSION 1 GRANTED
Friday, January 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 11, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 11, 2024SOU EXTENSION 2 FILED
Tuesday, June 11, 2024SOU EXTENSION 2 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED